Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers Gobburu JV, Agers H, Jusko WJ, Ynddal L Pharmaceutical Research (1999) This PK/PD study in human volunteers documented Ipamorelin's pharmacokinetic profile, showing peak GH concentrations approximately 30-40 minutes post-injection with effects lasting 2-3 hours
Unlike older compounds in the same class, it has relatively little activity on: Cortisol secretion Prolactin secretion Appetite stimulation This selectivity is one reason it remains popular in peptide protocols
While there is evidence that it can slow digestion and cause gastrointestinal discomfort, more studies are needed to determine how often it directly leads to acid reflux
Its distinct mechanism of action is what sets it apart
no clinician should prescribe retatrutide outside a formal clinical trial
Is Zepbound suitable for everyone